Use of low doses of oligonucleotides antisense to tgf-beta,...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7125 (2006.01) A61P 25/00 (2006.01) A61P 35/00 (2006.01) A61P 37/06 (2006.01)

Patent

CA 2591586

This invention is related to the use of at least one oligonucleotide with a length of from about 8 to about 30 nucleotide building blocks for manufacturing a pharmaceutical preparation for the prophylaxis and/or the treatment of diseases, that are modulated by TGF-beta2, TGF-beta1, TGF-beta3, VEGF, interleukin-10, c-jun, c-fos, and/or prostaglandin E2 in a mammal, in particular for the treatment of cancer, metastases, disease of the nervous system or immunosuppression, wherein said oligonucleotide hybridizes with a messenger RNA of a TGF-beta2, TGF-betal, TGF-beta3, VEGF, interleukin- 10, c- jun, c-fos and/or prostaglandin E2 gene and wherein said preparation comprises said oligonucleotide in a concentration of about 1 microM to about 25 microM.

L'invention concerne l'utilisation d'au moins un oligonucléotide d'une longueur d'environ 8 à environ 30 éléments constitutifs nucléotidiques dans la fabrication d'une préparation pharmaceutique destinée à la prévention et/ou au traitement de maladies induites par TGF-bêta2, TGF-bêta1, TGF-bêta3, VEGF, interleukine-10, c-jun, c-fos et/ou prostaglandine E2 chez un mammifère, cet oligonucléotide s'hybridant avec un ARN messager d'un gène de TGF-bêta2, TGF-bêta1, TGF-bêta3, VEGF, interleukine-10, c-jun, c-fos et/ou prostaglandine E2, la préparation selon l'invention contenant cet oligonucléotide dans une concentration comprise entre environ 1 microM et environ 25 microM.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of low doses of oligonucleotides antisense to tgf-beta,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of low doses of oligonucleotides antisense to tgf-beta,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of low doses of oligonucleotides antisense to tgf-beta,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1813592

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.